Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
US9901687B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9901687-B2 |
| Application number | US-201313868649-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 23, 2013 |
| Priority date | Jan 3, 2008 |
| Publication date | Feb 27, 2018 |
| Grant date | Feb 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In various embodiments, a needle is employed in refilling drug-delivery devices.
Opening claim text (preview).
What is claimed is: 1. An implantable drug-delivery device, comprising: a drug reservoir; a needle entry port comprising a throat for receiving a refill needle therethrough, the throat opening into a vestibule that is in fluid communication with the drug reservoir; and a visualization ring surrounding the needle entry port, the visualization ring being visible through ocular tissue so as to visually indicate a position of the needle entry port, wherein the vestibule (i) is wider than the throat, and (ii) comprises a stop on a wall opposite the throat for halting progress of a needle into the vestibule through the throat. 2. The implantable drug-delivery device of claim 1 , wherein the stop is sized so as to halt the progress of a needle comprising an exit port at a point at which the exit port is in fluid communication with the vestibule. 3. The implantable drug-delivery device of claim 1 , wherein a top surface of the stop is cupshaped. 4. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of a biocompatible material. 5. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of at least one of a metal, a plastic, or a composite material. 6. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of a material selected from the group consisting of PDMS, polyimide, polypropylene, PEEK, polycarbonate, an acetyl film, polyoxymethylene plastic, gold, stainless steel, nickel, and chrome. 7. The implantable drug-delivery device of claim 1 further comprising a check valve located between the vestibule and the drug reservoir. 8. The implantable drug-delivery device of claim 1 , wherein the needle entry port further comprises a self-sealing material. 9. The implantable drug-delivery device of claim 1 , wherein the visualization ring is constructed of a biocompatible material. 10. The implantable drug-delivery device of claim 1 , wherein the visualization ring is constructed of a material that withstands penetration by the refill needle. 11. The implantable drug-delivery device of claim 1 , wherein the visualization ring is visible through a patient's conjunctiva. 12. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a light emitting diode. 13. The implantable drug-delivery device of claim 1 further comprising a light emitting diode and optical fiber for conducting light from the light emitting diode to and around the visualization ring. 14. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a material that enhances surface echogenicity and acoustic shadowing. 15. The implantable drug-delivery device of claim 1 further comprising electronics to move or vibrate the visualization ring. 16. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a magnetic material. 17. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a fluorescent pigment. 18. The implantable drug-delivery device of claim 17 , wherein the fluorescent pigment is selected from the group consisting of a luminescent aerogel, a nanoparticle, a phthalocyanine pigment, fluorescein isothiocyanate, rhodamine, coumarin, cyanine, an Alexa Fluor, a DyLight Fluor, a quantum dot, a green fluorescent protein, and a luciferin.
by visual feedback · CPC title
Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body} · CPC title
having means for controlling depth of insertion · CPC title
by tactile feedback · CPC title
implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.